Scout | Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)

This opportunity is no longer accepting applications.

grant

Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)

The National Institute on Aging is inviting small businesses to apply for the Small Business Technology Transfer Research program. This grant supports research aimed at developing innovative products or services to prevent and treat Alzheimer's disease and related dementias, as well as improve care for patients living with these conditions.

Source

Agency: National Institutes of Health

Sub-agency: National Institute on Aging

Program: SBIR

Award

Award Ceiling: $1.8M

Funding Amount: $1.8M

Dates

Opportunity Released: June 21, 2022

Open for Submission: June 21, 2022

Submission Deadline: September 5, 2025

Application Window Closes: September 5, 2025

Keywords

Alzheimer's disease

dementia

small business

technology transfer

research funding

innovative products

patient care

treatment development

aging

NIA.

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers